IMPA1 抗体 (Middle Region)
-
- 抗原 See all IMPA1 抗体
- IMPA1 (Inositol(myo)-1(or 4)-Monophosphatase 1 (IMPA1))
-
抗原表位
- Middle Region
-
适用
- 人
-
宿主
- 兔
-
克隆类型
- 多克隆
-
标记
- This IMPA1 antibody is un-conjugated
-
应用范围
- Western Blotting (WB)
- 特异性
- IMPA1 antibody was raised against the middle region of IMPA1
- 纯化方法
- Affinity purified
- 免疫原
- IMPA1 antibody was raised using the middle region of IMPA1 corresponding to a region with amino acids IVTEAGGVLMDVTGGPFDLMSRRVIAANNRILAERIAKEIQVIPLQRDDE
- Top Product
- Discover our top product IMPA1 Primary Antibody
-
-
- 应用备注
-
WB: 1 µg/mL
Optimal conditions should be determined by the investigator. - 说明
-
IMPA1 Blocking Peptide, catalog no. 33R-4209, is also available for use as a blocking control in assays to test for specificity of this IMPA1 antibody
- 限制
- 仅限研究用
-
- 状态
- Lyophilized
- 溶解方式
- Lyophilized powder. Add distilled water for a 1 mg/mL concentration of IMPA1 antibody in PBS
- 浓度
- Lot specific
- 缓冲液
- PBS
- 注意事项
-
Avoid repeated freeze/thaw cycles.
Dilute only prior to immediate use. - 储存条件
- 4 °C/-20 °C
- 储存方法
- Store at 2-8 °C for short periods. For longer periods of storage, store at -20 °C.
-
- 抗原
- IMPA1 (Inositol(myo)-1(or 4)-Monophosphatase 1 (IMPA1))
- 别名
- IMPA1 (IMPA1 产品)
- 背景
- IMPA1 is responsible for the provision of inositol required for synthesis of phosphatidylinositol and polyphosphoinositides and has been implicated as the pharmacological target for lithium action in brain. IMPA1 can use myo-inositol monophosphates, myo-inositol-1,3-diphosphate, myo-inositol-1,4-diphosphate, scyllo-inositol-phosphate, glucose-1-phosphate, glucose-6-phosphate, fructose-1-phosphate, beta-glycerophosphate, and 2'-AMP as substrates.
- 分子量
- 30 kDa (MW of target protein)
-